Lifecore Biomedical, Inc. LFCR
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 09/30/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 135.27M | 135.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 135.27M | 135.27M |
| Cost of Revenue | -- | -- | -- | 92.57M | 92.57M |
| Gross Profit | -- | -- | -- | 42.70M | 42.70M |
| SG&A Expenses | -- | -- | -- | 38.68M | 38.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | 139.29M | 139.29M |
| Operating Income | -- | -- | -- | -4.02M | -4.02M |
| Income Before Tax | -- | -- | -- | -32.08M | -32.08M |
| Income Tax Expenses | -- | -- | -- | 401.00K | 401.00K |
| Earnings from Continuing Operations | -- | -- | -- | -32.48 | -32.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -32.48M | -32.48M |
| EBIT | -- | -- | -- | -4.02M | -4.02M |
| EBITDA | -- | -- | -- | 4.00M | 4.00M |
| EPS Basic | -- | -- | -- | -1.07 | -1.07 |
| Normalized Basic EPS | -- | -- | -- | -0.47 | -0.47 |
| EPS Diluted | -- | -- | -- | -1.07 | -1.07 |
| Normalized Diluted EPS | -- | -- | -- | -0.47 | -0.47 |
| Average Basic Shares Outstanding | -- | -- | -- | 145.79M | 145.79M |
| Average Diluted Shares Outstanding | -- | -- | -- | 145.79M | 145.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |